TAYLOR WILSON: Open Payments
NPI 1861152019 · PITTSBURGH, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,386 in 61 payments from 9 companies in 2025. Trend: 2023 $899 · 2024 $1,120 · 2025 $1,386
Food & beverage: $1,386
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 42 | $937 |
| Axsome Therapeutics, Inc. | 11 | $275 |
| Sage Therapeutics, LLC | 1 | $38 |
| Supernus Pharmaceuticals, Inc. | 2 | $32 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $29 |
| Alkermes, Inc. | 1 | $23 |
| Teva Pharmaceuticals USA, Inc. | 1 | $19 |
| Collegium Pharmaceutical, Inc. | 1 | $18 |
| Vanda Pharmaceuticals Inc. | 1 | $15 |
Products named: VRAYLAR, Auvelity, ZURZUVAE, Qelbree, CAPLYTA, ARISTADA, AUSTEDO XR, Jornay PM.
Industry payments across PA — which companies pay providers there.
